6-bromo-N-tert-butylimidazo[1,2-a]pyrazin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde

C183H192BBr7N28O20 — CID 160765093

About 6-bromo-N-tert-butylimidazo[1,2-a]pyrazin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde

6-bromo-N-tert-butylimidazo[1,2-a]pyrazin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde (PubChem CID 160765093) has the molecular formula C183H192BBr7N28O20 and a molecular weight of 3673.86 g/mol. Its IUPAC name is 6-bromo-N-tert-butylimidazo[1,2-a]pyrazin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde.

Molecular Properties

• Compound Name: 6-bromo-N-tert-butylimidazo[1,2-a]pyrazin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde
• PubChem CID: 160765093
• Molecular Formula: C183H192BBr7N28O20
• Molecular Weight: 3673.86 g/mol
• Exact Mass: 3664.92
• IUPAC Name: 6-bromo-N-tert-butylimidazo[1,2-a]pyrazin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde
• SMILES: CC(=O)OCc1c(-c2cn3ccnc3c(NC(C)(C)C)n2)cccc1-n1ncc2cc(C(C)(C)C)ccc2c1=O.CC(=O)OCc1c(B2OC(C)(C)C(C)(C)O2)cccc1-n1ncc2cc(C(C)(C)C)ccc2c1=O.CC(=O)OCc1c(Br)cccc1-n1ncc2cc(C(C)(C)C)ccc2c1=O.CC(C)(C)Nc1nc(-c2cccc(-n3ncc4cc(C(C)(C)C)ccc4c3=O)c2CO)cn2ccnc12.CC(C)(C)Nc1nc(Br)cn2ccnc12.CC(C)(C)c1ccc2c(=O)[nH]ncc2c1.CC(C)(C)c1ccc2c(=O)n(-c3cccc(Br)c3C=O)ncc2c1.CC(C)(C)c1ccc2c(=O)n(-c3cccc(Br)c3CO)ncc2c1.O=Cc1c(Br)cccc1Br.O=c1[nH]ncc2cc(Br)ccc12
• InChI: InChI=1S/C31H34N6O3.C29H32N6O2.C27H33BN2O5.C21H21BrN2O3.C19H19BrN2O2.C19H17BrN2O2.C12H14N2O.C10H13BrN4.C8H5BrN2O.C7H4Br2O/c1-19(38)40-18-24-23(25-17-36-14-13-32-28(36)27(34-25)35-31(5,6)7)9-8-10-26(24)37-29(39)22-12-11-21(30(2,3)4)15-20(22)16-33-37;1-28(2,3)19-10-11-20-18(14-19)15-31-35(27(20)37)24-9-7-8-21(22(24)17-36)23-16-34-13-12-30-26(34)25(32-23)33-29(4,5)6;1-17(31)33-16-21-22(28-34-26(5,6)27(7,8)35-28)10-9-11-23(21)30-24(32)20-13-12-19(25(2,3)4)14-18(20)15-29-30;1-13(25)27-12-17-18(22)6-5-7-19(17)24-20(26)16-9-8-15(21(2,3)4)10-14(16)11-23-24;2*1-19(2,3)13-7-8-14-12(9-13)10-21-22(18(14)24)17-6-4-5-16(20)15(17)11-23;1-12(2,3)9-4-5-10-8(6-9)7-13-14-11(10)15;1-10(2,3)14-8-9-12-4-5-15(9)6-7(11)13-8;9-6-1-2-7-5(3-6)4-10-11-8(7)12;8-6-2-1-3-7(9)5(6)4-10/h8-17H,18H2,1-7H3,(H,34,35);7-16,36H,17H2,1-6H3,(H,32,33);9-15H,16H2,1-8H3;5-11H,12H2,1-4H3;4-10,23H,11H2,1-3H3;4-11H,1-3H3;4-7H,1-3H3,(H,14,15);4-6H,1-3H3,(H,13,14);1-4H,(H,11,12);1-4H
• InChIKey: RYOQUIJFRPCFHY-UHFFFAOYSA-N
• XLogP: 37.15
• TPSA: 599.46 Ų
• H-Bond Donors: 7
• H-Bond Acceptors: 46
• Rotatable Bonds: 22
• Heavy Atoms: 239
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3673.86
LogP ≤ 5	37.15
H-Bond Donors ≤ 5	7
H-Bond Acceptors ≤ 10	46

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 6-bromo-N-tert-butylimidazo[1,2-a]pyrazin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde?

The IUPAC name of 6-bromo-N-tert-butylimidazo[1,2-a]pyrazin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde (CID 160765093) is 6-bromo-N-tert-butylimidazo[1,2-a]pyrazin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde.

What is the SMILES notation for 6-bromo-N-tert-butylimidazo[1,2-a]pyrazin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde?

The canonical SMILES for 6-bromo-N-tert-butylimidazo[1,2-a]pyrazin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde is CC(=O)OCc1c(-c2cn3ccnc3c(NC(C)(C)C)n2)cccc1-n1ncc2cc(C(C)(C)C)ccc2c1=O.CC(=O)OCc1c(B2OC(C)(C)C(C)(C)O2)cccc1-n1ncc2cc(C(C)(C)C)ccc2c1=O.CC(=O)OCc1c(Br)cccc1-n1ncc2cc(C(C)(C)C)ccc2c1=O.CC(C)(C)Nc1nc(-c2cccc(-n3ncc4cc(C(C)(C)C)ccc4c3=O)c2CO)cn2ccnc12.CC(C)(C)Nc1nc(Br)cn2ccnc12.CC(C)(C)c1ccc2c(=O)[nH]ncc2c1.CC(C)(C)c1ccc2c(=O)n(-c3cccc(Br)c3C=O)ncc2c1.CC(C)(C)c1ccc2c(=O)n(-c3cccc(Br)c3CO)ncc2c1.O=Cc1c(Br)cccc1Br.O=c1[nH]ncc2cc(Br)ccc12.

What is the InChIKey of 6-bromo-N-tert-butylimidazo[1,2-a]pyrazin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde?

The InChIKey is RYOQUIJFRPCFHY-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H34N6O3.C29H32N6O2.C27H33BN2O5.C21H21BrN2O3.C19H19BrN2O2.C19H17BrN2O2.C12H14N2O.C10H13BrN4.C8H5BrN2O.C7H4Br2O/c1-19(38)40-18-24-23(25-17-36-14-13-32-28(36)27(34-25)35-31(5,6)7)9-8-10-26(24)37-29(39)22-12-11-21(30(2,3)4)15-20(22)16-33-37;1-28(2,3)19-10-11-20-18(14-19)15-31-35(27(20)37)24-9-7-8-21(22(24)17-36)23-16-34-13-12-30-26(34)25(32-23)33-29(4,5)6;1-17(31)33-16-21-22(28-34-26(5,6)27(7,8)35-28)10-9-11-23(21)30-24(32)20-13-12-19(25(2,3)4)14-18(20)15-29-30;1-13(25)27-12-17-18(22)6-5-7-19(17)24-20(26)16-9-8-15(21(2,3)4)10-14(16)11-23-24;2*1-19(2,3)13-7-8-14-12(9-13)10-21-22(18(14)24)17-6-4-5-16(20)15(17)11-23;1-12(2,3)9-4-5-10-8(6-9)7-13-14-11(10)15;1-10(2,3)14-8-9-12-4-5-15(9)6-7(11)13-8;9-6-1-2-7-5(3-6)4-10-11-8(7)12;8-6-2-1-3-7(9)5(6)4-10/h8-17H,18H2,1-7H3,(H,34,35);7-16,36H,17H2,1-6H3,(H,32,33);9-15H,16H2,1-8H3;5-11H,12H2,1-4H3;4-10,23H,11H2,1-3H3;4-11H,1-3H3;4-7H,1-3H3,(H,14,15);4-6H,1-3H3,(H,13,14);1-4H,(H,11,12);1-4H.

What are the key properties of 6-bromo-N-tert-butylimidazo[1,2-a]pyrazin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde?

6-bromo-N-tert-butylimidazo[1,2-a]pyrazin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde has a molecular weight of 3673.86 g/mol, XLogP of 37.15, 22 rotatable bonds, 7 hydrogen bond donors, and 46 hydrogen bond acceptors.

Where does this data come from?

All data for 6-bromo-N-tert-butylimidazo[1,2-a]pyrazin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde is sourced from PubChem (CID 160765093), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).